Journal: Laboratory Investigation; a Journal of Technical Methods and Pathology
Article Title: Identification of inhibitors regulating cell proliferation and FUS-DDIT3 expression in myxoid liposarcoma using combined DNA, mRNA, and protein analyses
doi: 10.1038/s41374-018-0046-3
Figure Lengend Snippet: Kinase inhibitor validation. MLS 402–91, 2645–94 and 1765–92 cells were treated with 12 kinase inhibitors (2.5 µM) and compared to treatment controls (DMSO). Cells from three wells on the same 96-well plate were analyzed in three to four independent cell culturing experiments. A Cell proliferation. The DMSO control was arbitrarily set to a value of zero. Different gDNA assays were used for each MLS cell line based on the NormFinder algorithm (Supplementary Table ). Mean ± SEM is shown, n = 3–4. B FUS-DDIT3 and FUS mRNA expressions. The DMSO controls were arbitrarily set to a value of zero. Mean ± SEM is shown, n = 3–4. C FUS-DDIT3 and FUS protein expressions. The DMSO controls were arbitrarily set to a value of zero. Note that FUS alone cannot be quantified with our PLA in MLS 1765–92. Mean ± SEM is shown, n = 3–4
Article Snippet: To identify signaling pathways that regulate cell proliferation and FUS-DDIT3 regulation, a library of kinase inhibitors targeting stem cell signaling was applied (#L2100, Selleck chemical).
Techniques: Biomarker Discovery, Cell Culture, Control